J Korean Ophthalmol Soc.
2003 Sep;44(9):1991-1995.
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Pathologic Myopia
- Affiliations
-
- 1The Institute of Vision Research, Department of Ophthalmology, College of Medicine, Yonsei University, Seoul, Korea. sunglee@yumc.yonsei.ac.kr
- 2Department of Ophthalmology, Daejin medical center, Boondang, Kyonggi, Korea.
Abstract
- PURPOSE
To evaluate short-term safety and the effects on visual acuity and fluorescein angiography of photodynamic therapy with verteporfin for myopic choroidal neovascularization (CNV). METHODS: Ten patients with CNV secondary to pathologic myopia were included. The results of refraction, visual acuity testing, ophthalmic examinations, fluorescein angiography, and optical coherence tomography were evaluated following photodynamic therapy with verterporfin.
RESULTS
Deterioration in visual acuity was not observed. No one lost more than eight letters. Six patients showed visual improvement by at least five letters. Size of fluorescein leakage was reduced in eight of patients after verteporfin therapy.
CONCLUSIONS
Photodynamic therapy with verteporfin may safely improve or stabilize vision in patients with subfoveal CNV from pathologic myopia.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Photodynamic Therapy For Recurred Subfoveal Choroidal Neovascularization After Argon-Laser Photocoagulation
- Photodynamic Therapy in Practice: A Review of Experiences with Myopic CNV in Korean Patients
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization-Interval and Number of Application of Verteporfin Treatment
- A Case of Subfoveal Choroidal Neovascularization following Multiple Evanescent White-Dot Syndrome
- Photodynamic Therapy with Verteporfin for Subfoveal Choroidal Neovascularization in Vogt-Koyanagi-Harada Syndrome
